We are live on ! Find out more
AC

Aisling Capital Portfolio holdings

AUM $45.3M
1-Year Est. Return 15.24%
This Fund
S&P 500
This Quarter Est. Return
+8.04%
1 Year Est. Return
-15.24%
3 Year Est. Return
+386.13%
5 Year Est. Return
+981.36%
10 Year Est. Return
–
AUM
$164M
AUM Growth
–
Cap. Flow
+$152M
Cap. Flow %
92.81%
Top 10 Hldgs %
100%
Holding
6
New
6
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$79.9M
2
DRTX
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
+$32.8M
3
CMRX
Chimerix, Inc.
CMRX
+$19.5M
4
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$7.95M
5
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$5.46M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 68.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQV icon
1
IQVIA
IQV
$33.1B
$84.5M 51.65%
+1,823,575
New +$79.9M
DRTX
2
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
$40M 24.45%
+3,130,824
New +$32.8M
CMRX
3
DELISTED
Chimerix, Inc.
CMRX
$18.5M 11.31%
+1,222,943
New +$19.5M
ICPT
4
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$9.4M 5.75%
+137,519
New +$7.95M
SRNE
5
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$5M 3.06%
+620,700
New +$5.46M

Similar funds

SCPM
Sagard Capital Partners Management New York $46.7M AUM 23.43% 1-Year Est. Return
ZIM
ZPR Investment Management Orange City, Florida $46.8M AUM 2.45% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return
INL
IPC/NYCG LLC New York $43.3M AUM 61.41% 1-Year Est. Return
CP
Clover Partners Dallas, Texas $43.1M AUM 4.09% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
JCM
Julex Capital Management Wellesley, Massachusetts $42.4M AUM 9.78% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return

Aisling Capital's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Aisling Capital, which disclosed 6 positions worth $164M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is IQVIA: 1,823,575 shares worth $84.5M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets.

  • Aisling Capital's largest Q4 2013 buy was IQVIA: 1,823,575 shares worth $84.5M.
  • Aisling Capital's ten largest holdings make up 100% of its $164M portfolio in Q4 2013.
  • Aisling Capital disclosed 6 positions in Q4 2013, its first 13F filing on record.

Based on Aisling Capital's 13F filing for Q4 2013, filed 13 Feb 2014.